Evaluation of platelets activity and reactivity as risk factors for acute ischemic non-embolic stroke in young adults

Table 6 Correlation between patient vascular risk factors and platelet activity and reactivity

	Age		Gender		HTN		DM		FH		IS recurrence
	R	p-value	R	p-value	R	p-value	R	p-value	R	p-value	R	p-value
Baseline CD62P %	0.15	0.08	0.01	0.09	0.09	0.3	− 0.1	0.2	− 0.05	0.9	0.06	0.5
Baseline CD62P MFI	− 0.22	0.014*	0.03	0.7	− 0.05	0.5	− 0.08	0.3	− 0.1	0.1	− 0.08	0.3
ADP induced CD62P%	− 0.18	0.049*	− 0.17	0.08	0.08	0.3	0.02	0.7	0.1	0.2	0.15	0.09
ADP induced MFI	− 0.15	0.09	− 0.06	0.49	− 0.45	0.6	− 0.1	0.07	− 0.06	0.4	− 0.16	0.8

	PLT count		MPV		WBC		Total cholesterol		LDL		TG
	R	p-value	R	p-value	R	p-value	R	p-value	R	p-value	R	p-value
Baseline CD62P %	− 0.03	0.07	0.2	0.01*	0.07	0.4	0.08	0.3	0.06	0.4	0.07	0.4
Baseline CD62P MFI	0.04	0.6	− 0.07	0.4	− 0.08	0.3	− 0.1	0.2	0.1	0.09	0.1	0.03*
ADP induced CD62P%	− 0.02	0.08	0.1	0.02*	0.1	0.2	0.2	0.09	0.3	0.005*	0.1	0.12
ADP induced MFI	0.04	0.06	0.004	0.9	− 0.04	0.6	− 0.1	0.07	0.03	0.7	− 0.16	0.2

FH family history, HTN hypertension, DM diabetes mellitus, MPV mean platelet volume, TG triglycerides, LDL low-density lipoproteins, r (correlation coefficient) is statistically significant at level of p < 0.05. CD cluster of differentiation, ADP adenosine di-phosphate
bold indicates statistically significant relation
italic indicates the type of the test used